Unlabelled: Diabetic retinopathy is considered a low-grade chronic inflammatory disease and several inflammatory molecules, including tumor necrosis factor (TNF)-α, are known to play a major role in the degeneration of retinal capillaries. Previous studies have reported that sitagliptin, a DPP-4 inhibitor, prevents the increase in blood-retinal barrier (BRB) permeability and inhibits the tight junction disassembly induced by diabetes.
Aim: Our goal was to investigate whether sitagliptin is able to prevent retinal endothelial cells (EC) dysfunction triggered by the pro-inflammatory cytokine TNF-α.
Main Methods: The effects of TNF-α and/or sitagliptin on primary cultures of bovine retinal EC were tested. The EC monolayer permeability was analyzed by using 70 kDa rhodamine isothiocyanate (RITC) dextran. The cellular distribution profile of claudin-5 was examined by immunofluorescence staining, and DPP-4 activity was evaluated by using a fluorogenic substrate. Cell viability was assessed by MTT assay, and cell proliferation by the BrdU incorporation assay. Retinal EC migration and angiogenesis were evaluated by a scratch assay and a capillary tube formation in matrigel assay, respectively.
Key Findings: TNF-α increased the permeability of EC monolayer and induced the loss of claudin-5 immunostaining at the cell borders. This impairment was associated with decreased migration and capillary morphogenesis of retinal EC. Sitagliptin was unable to prevent the effect of TNF-α on EC permeability. However, it decreased DPP-4 activity in bovine retinal EC exposed to TNF-α, without affecting cell viability. Moreover, sitagliptin enhanced the migration and capillary morphogenesis in bovine retinal EC challenged with TNF-α.
Significance: These results suggest that sitagliptin is able to positively modulate vascular EC function under conditions of retinal inflammation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.biopha.2018.03.144 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mode-Specific Photoresponse of Retinal Protonated Schiff Base Isomers in the Reversible Photochromic Reactions of Microbial and Animal Rhodopsins.
J Phys Chem B
December 2024
Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1/3, Moscow 119991, Russia.
The primary photoisomerization reactions of the all- to 13- and 11- to all- retinal protonated Schiff base (RPSB) in microbial and animal rhodopsins, respectively, occur on a subpicosecond time scale with high quantum yields. At the same time, the isolated RPSB exhibits slower excited-state decay, in particular, in its all- form, and hence the interaction with the protein environment is capable of changing the time scale as well as the specificity of the reaction. Here, by using the high-level QM/MM calculations, we provide a comparative study of the primary photoresponse of and RPSB isomers in both the initial forms and first photoproducts of microbial rhodopsin 2 (KR2) and bacteriorhodopsin (BR), and animal visual rhodopsin (Rho).
View Article and Find Full Text PDFMechanisms of amphibian arrestin 1 self-association and dynamic distribution in retinal photoreceptors.
J Biol Chem
December 2024
Center for Vision Research and the Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, USA. Electronic address:
Article Synopsis
- Visual arrestin 1 (Arr1) is crucial for stopping the light response in photoreceptors, and while its dimer and tetramer formations have been studied in mammals, similar research in amphibians is lacking.
- In this study, the dimerization of Arr1 from two amphibian species, Xenopus laevis and Ambystoma tigrinum, revealed that both proteins primarily form dimers with similar dissociation constants (K) to mammalian Arr1.
- Crystallography and other techniques identified two potential dimer structures for amphibian Arr1, suggesting that the interaction between dimer forms may influence their stability and that the distribution of Arr1 in dark-adapted photoreceptors is impacted by
Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat.
Invest Ophthalmol Vis Sci
November 2024
Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Campus Juriquilla, Universidad Nacional Autónoma de México, Querétaro, Qro., México.
Purpose: Growth hormone (GH) has neuroprotective effects that have not been evaluated in the mammalian visual system. This study tested the hypothesis that GH administration can promote retinal neuroprotection in an optic nerve crush (ONC) model in male rats.
Methods: The ON was compressed for 10 seconds, and bovine GH was injected concomitantly to injury for 14 days (0.
Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae.
Pharmaceuticals (Basel)
October 2024
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.
We have evidence that hydrogen sulfide (HS)-releasing compounds can reduce intraocular pressure in normotensive and glaucomatous rabbits by increasing the aqueous humor (AH) outflow through the trabecular meshwork. Since HS has been reported to possess neuroprotective actions, the prevention of retinal ganglion cell loss is an important strategy in the pharmacotherapy of glaucoma. Consequently, the present study aimed to investigate the neuroprotective actions of HS-releasing compounds against hydrogen peroxide (HO)-induced oxidative stress in an isolated bovine retina.
View Article and Find Full Text PDFDo preterm infants' retinas like bovine colostrum? A randomized controlled trial.
Ital J Pediatr
October 2024
Pediatrics and Neonatology, Pediatric Department, Alexandria University Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Article Synopsis
- Bovine colostrum (BC) delivered via a liposomal system was tested as a supplement for premature infants, aiming to reduce the incidence of retinopathy of prematurity (ROP) due to its multiple beneficial factors for retinal development.
- A controlled trial involving 211 preterm infants found that those receiving BC had a significantly lower incidence of ROP compared to those who did not receive it (5% vs. 16%), along with improved growth and lower rates of suspected sepsis.
- The study concluded that BC intake positively impacted health outcomes in preterm infants, particularly reducing ROP, enhancing hemoglobin levels, and contributing to weight gain, although weight gain was the strongest predictor of reduced ROP.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!